Startups
Acting in the public interest, DNDi bridges the existing R&D gaps in essential drugs for neglected diseases by initiating and coordinating drug R&D projects in collaboration with the international research community, public sector, pharmaceutical industry, and other relevant partners. In doing so, DNDi also works to use and strengthen existing research and treatment capacities in disease-endemic countries, and raise awareness and advocate for the need to develop new treatments for the most neglected diseases.
Overview
Location
Switzerland, Geneva
Employees
201-500
Phone
+41 22 906 92 30
Founded date
2003
Mentions in press and media 13
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 3, 2026 | Total Investment of Approx. USD 8.8 Million in Malaria, Tuberculosis, and NTD R&D Projects with Partners Including Mahidol University, Barcelona Institute for Global Health, and Eisai | TOKYO, Feb. 3, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.39 billion (USD 8.8 million1) in six R&D projects for the development of drugs, diagnostic... |
| Apr 16, 2025 | WHO member countries agree on a draft ‘pandemic treaty’ to try to avoid COVID-19 mistakes | Weeks after Trump’s decision, Argentina’s President Javier Milei also exited the WHO, citing “profound differences” with the U.N. agency. Related Articles Rural hospitals and patients are disconnected from modern care Draft budget plan prop... |
| May 9, 2024 | Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions | TOKYO, May 9, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.64 billion (USD 10.8 million1) in four projects for the development of new drugs for malaria an... |
| Oct 17, 2022 | BMBF supports the research of innovative antibiotics with another 50 million euros | The German Federal Ministry of Education and Research (BMBF) is supporting the non-profit initiative 'Global Antibiotic Research & Development Partnership' with a further 50 million euros for the research and development of ur... |
| Jul 22, 2021 | DeepMind open-sources protein structure dataset generated by AlphaFold 2 | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today! DeepMind and the European Bioinformatics Institut... |
| Jul 22, 2021 | DeepMind open-sources protein structure dataset generated by AlphaFold 2 | All the sessions from Transform 2021 are available on-demand now. Watch now. DeepMind and the European Bioinformatics Institute (EMBL), a life sciences lab based in Hinxton, England, today announced the launch of what they claim is the most... |
| Nov 24, 2020 | Now is the time to innovate for more than 1 billion people with neglected tropical diseases | With the first results of multiple Covid-19 vaccine candidates giving hope to billions of people around the world, the power of biomedical research has captured the public’s attention. The speed with which it moved to develop vaccines, trea... |
| Jan 29, 2020 | Record Funding For Global Health Research, But Neglected Tropical Diseases Remain Neglected | LEOGANE, HAITI - MAY 25: Two female patients of Dr. Luccene Desir, director of the Center of ... [+] Research for Filariasis in Haiti (elephantiasis) display their legs affected by elephantiasis at a hospital in Leogane, south of Pt-au-Prin... |
| Jan 21, 2019 | The Warren bill could promote beneficial public-private partnerships in life sciences | Bills like the Affordable Drug Manufacturing Act, if enacted, could help a beneficial trend gather momentum in 2019: life sciences companies making public-private partnerships a bigger focus of their business strategies. The bill, proposed ... |
Show more
Reviews 0
FAQ about DNDi
When was DNDi founded?
DNDi was founded in 2003.
What has the press written about DNDi?
Parsers VC has collected 13 articles mentioning DNDi, among them “Total Investment of Approx. USD 8.8 Million in Malaria, Tuberculosis, and NTD R&D Projects with Partners Including Mahidol University, Barcelona Institute fo...” (Feb 3, 2026) and “WHO member countries agree on a draft ‘pandemic treaty’ to try to avoid COVID-19 mistakes” (Apr 16, 2025).
Is DNDi still active?
Yes, DNDi is active; its latest activity on Parsers VC dates from Oct 29, 2026.